BioSpace News Archive

Business

Marken Establishes New Collaboration With RareChannels

Collaboration Paves Way for Manufacturers to Find Logistics Solutions for Patients

November 20, 2018
·
3 min read
Edwards Lifesciences and Medtronic Lead the U.S. TAVR Market, Despite Threat of New Competition – New Analysis from iData Research

According to a new series of reports by iData Research, the United States cardiac surgery device market is valued at $5.7 billion USD and is forecast to exceed $10 billion by 2024.

November 20, 2018
·
2 min read
Drug Development

Stallergenes Greer Announces That the Phase III Trial for Its Sublingual Allergy Immunotherapy Tablet STAGR320 to Treat House Dust Mite-Induced Allergic Rhinitis Achieved Its Primary Endpoint

The study achieved its primary efficacy endpoint (p<0.0001)

November 20, 2018
·
9 min read
2018 Report Card Outlines Bold Ambitions for Child and Family Poverty Eradication

With the 2019 federal election under a year away, all parties should embrace bold ambitions to eradicate child and family poverty in Canada, says Campaign 2000.

November 20, 2018
·
5 min read
Deals

Revelstoke Capital Partners Closes 50Th Transaction in 5 Years

Crossroads Holding, LLC has completed its acquisition of EHC Medical Offices

November 20, 2018
·
3 min read
Business

Ascletis and Roche enter exclusive Pegasys partnership in China for viral Hepatitis

Shanghai Roche Pharmaceuticals Ltd. and Ascletis BioScience Co., Ltd. jointly announce that starting from 1st Dec 2018, Ascletis and Roche will expand their partnership in viral Hepatitis.

November 20, 2018
·
2 min read
Canada’s drug spending growth outpaces that for hospitals and doctors

Canada is expected to spend $33.7 billion on prescribed drugs in 2018, according to the Canadian Institute for Health Information (CIHI).

November 20, 2018
·
3 min read
Policy

GB Sciences Files First Of Its Kind Provisional Patent Application For The Treatment Of Neuropathic Pain Using Time-Released, Myrcene-Based Nanoparticles

First of their kind, myrcene nanoparticles are central to a novel, time-released therapeutic for neuropathic pain

November 20, 2018
·
4 min read
Business

Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2019 Financial Results

Earnings Call Scheduled for 8:00 a.m. ET on November 28, 2018

November 20, 2018
·
2 min read
Business

LEO Pharma and PellePharm Announce $760 Million Collaboration to Advance Innovative Therapies for Rare Skin Diseases

LEO Pharma A/S acquires minority stake in PellePharm and provides additional non-dilutive capital to fund PellePharm development programs; obtains option to acquire all shares in PellePharm

November 20, 2018
·
7 min read